Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

Luis Paz-Ares, Alexander Luft, David Vicente, Ali Tafreshi, Mahmut Gümüş, Julien Mazières, Barbara Hermes, Filiz Çay Şenler, Tibor Csőszi, Andrea Fülöp, Jerónimo Rodríguez-Cid, Jonathan Wilson, Shunichi Sugawara, Terufumi Kato, Ki Hyeong Lee, Ying Cheng, Silvia Novello, Balazs Halmos, Xiaodong Li, Gregory M. Lubiniecki, Bilal Piperdi, Dariusz M. Kowalski

Open source

DOI: 10.1056/nejmoa1810865
Published: 2018-11-22
Container: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa1810865,
  title = {Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer},
  author = {Luis Paz-Ares and Alexander Luft and David Vicente and Ali Tafreshi and Mahmut Gümüş and Julien Mazières and Barbara Hermes and Filiz Çay Şenler and Tibor Csőszi and Andrea Fülöp and Jerónimo Rodríguez-Cid and Jonathan Wilson and Shunichi Sugawara and Terufumi Kato and Ki Hyeong Lee and Ying Cheng and Silvia Novello and Balazs Halmos and Xiaodong Li and Gregory M. Lubiniecki and Bilal Piperdi and Dariusz M. Kowalski},
  year = {2018},
  journal = {New England Journal of Medicine},
  doi = {10.1056/nejmoa1810865},
  url = {https://doi.org/10.1056/nejmoa1810865}
}

RIS

TY  - JOUR
TI  - Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
AU  - Luis Paz-Ares
AU  - Alexander Luft
AU  - David Vicente
AU  - Ali Tafreshi
AU  - Mahmut Gümüş
AU  - Julien Mazières
AU  - Barbara Hermes
AU  - Filiz Çay Şenler
AU  - Tibor Csőszi
AU  - Andrea Fülöp
AU  - Jerónimo Rodríguez-Cid
AU  - Jonathan Wilson
AU  - Shunichi Sugawara
AU  - Terufumi Kato
AU  - Ki Hyeong Lee
AU  - Ying Cheng
AU  - Silvia Novello
AU  - Balazs Halmos
AU  - Xiaodong Li
AU  - Gregory M. Lubiniecki
AU  - Bilal Piperdi
AU  - Dariusz M. Kowalski
PY  - 2018
JO  - New England Journal of Medicine
DO  - 10.1056/nejmoa1810865
UR  - https://doi.org/10.1056/nejmoa1810865
ER  -

APA

Paz-Ares, L., Luft, A., Vicente, D., Tafreshi, A., Gümüş, M., Mazières, J., Hermes, B., Şenler, F. Ç., Csőszi, T., Fülöp, A., Rodríguez-Cid, J., Wilson, J., Sugawara, S., Kato, T., Lee, K. H., Cheng, Y., Novello, S., Halmos, B., Li, X., Lubiniecki, G. M., Piperdi, B., & Kowalski, D. M. (2018). Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1810865

Source records

crossref · retrieved 2026-09-27T16:23:44.924Z